Tokyo, Jan. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060259) titled 'Very long-term follow-up of ischemic heart disease after index PCI - cumulative events and secondary prevention' on Jan. 9.
Study Type:
Observational
Primary Sponsor:
Institute - Shizuoka City Shizuoka Hospital
Condition:
Condition - ischemic heart disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Shizuoka City has a limited number of medical institutions capable of performing primary PCI, and medical resources are limited, but it is relatively easy to track patients who have undergone intervention over the long term.
We will conduct ultra-long-term follow-up of PCI cases at our facility for more than 10 years to evaluate the effectiveness and characteristics of treatment. While the study will primarily be observational, some will involve continuous intervention in collaboration with hospitals and clinics, and fatal events will be avoided by optimal drug therapy based on the latest evidence and early testing to identify signs of disease recurrence.
In addition, we will use the overall observation of long-term prognosis to build a foundation for building evidence for better secondary prevention.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Established ischemic heart disease with index PCI procedure(s)
Key exclusion criteria - those who do not reach 1 year follow-up
Target Size - 3800
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2018 Year 09 Month 14 Day
Date of IRB - 2020 Year 07 Month 15 Day
Anticipated trial start date - 2018 Year 11 Month 01 Day
Last follow-up date - 2025 Year 12 Month 24 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068926
Disclaimer: Curated by HT Syndication.
